4
Changes in Ownership
abrdn Life Sciences Investors Filed Acc 0001510281-24-000270
10% owner bought 26,526 shares at an average $13.46 ($356,929)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. 10% owner | 2024-05-01 | Purchase | +252 | $13.02 | $3,281 | 3,042,456 | I: show line 1 in the form |
| Saba Capital Management, L.P. 10% owner | 2024-05-02 | Purchase | +26,274 | $13.46 | $353,648 | 3,068,730 | I: show line 2 in the form |
| Open-market purchases · 26,526 sh · avg $13.46 · $356,929 | |||||||
Loading xslF345X05/primary_doc.xml…